Postnatal Hypoxia and the Developing Brain: Cellular and Molecular Mechanisms of Injury

Contemporary Clinical Neuroscience

Volumn , Issue , 2009, Pages 255-276

  Douglas, Robert M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Central Nervous System; Development; HIF 1 ; Hypoxia; Neonate; NF B; ROS

Indexed keywords

EID: 70450284953     PISSN: 2627535X     EISSN: 26275341     Source Type: Book Series    
DOI: 10.1007/978-1-60327-579-8_13     Document Type: Chapter

References (203)

1. Roach RC, Hackett PH. Frontiers of hypoxia research: acute mountain sickness. J Exp Biol 2001;204 (Part 18):3161–70.
2. Hornbein TF. The high-altitude brain. J Exp Biol 2001;204 (Part 18):3129–32.
3. Wiegand L, Zwillich CW. Obstructive sleep apnea. Dis Mon 1994;40(4):197–252.
4. Neubauer JA. Invited review: physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol 2001;90(4):1593–9.
5. Weese-Mayer DE, Silvestri JM, Menzies LJ, Morrow-Kenny AS, Hunt CE, Hauptman SA. Congenital central hypoventilation syndrome: diagnosis, management, and long-term outcome in thirty-two children. J Pediatr 1992;120(3):381–7.
6. Owens J, Spirito A, Nobile C, Arrigan M. Incidence of parasomnias in children with obstructive sleep apnea. Sleep 1997;20(12):1193–6.
7. Corno AF, Milano G, Samaja M, Tozzi P, von Segesser LK. Chronic hypoxia: a model for cyanotic congenital heart defects. J Thorac Cardiovasc Surg 2002;124(1):105–12.
8. Badr Zahr LK, Purdy I. Brain injury in the infant: the old, the new, and the uncertain. J Perinat Neonatal Nurs 2006;20(2):163–75; quiz 76–7.
9. Johnston MV. Brain plasticity in paediatric neurology. Eur J Paediatr Neurol 2003;7(3): 105–13.
10. Johnson EM, Jr., Deckwerth TL. Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci 1993;16:31–46.
11. Blaschke AJ, Staley K, Chun J. Widespread programmed cell death in proliferative and post-mitotic regions of the fetal cerebral cortex. Development 1996;122(4):1165–74.
12. Lopez-Bendito G, Molnar Z. Thalamocortical development: how are we going to get there? Nat Rev Neurosci 2003;4(4):276–89.
13. Bonhoeffer T. Neurotrophins and activity-dependent development of the neocortex. Curr Opin Neurobiol 1996;6(1):119–26.
14. Berardi N, Pizzorusso T, Maffei L. Critical periods during sensory development. Curr Opin Neurobiol 2000;10(1):138–45.
15. Curristin SM, Cao A, Stewart WB, et al. Disrupted synaptic development in the hypoxic newborn brain. Proc Natl Acad Sci USA 2002;99(24):15729–34.
16. Ment LR, Schwartz M, Makuch RW, Stewart WB. Association of chronic sublethal hypoxia with ventriculomegaly in the developing rat brain. Brain Res Dev Brain Res 1998; 111(2):197–203.
17. Weiss J, Takizawa B, McGee A, et al. Neonatal hypoxia suppresses oligodendrocyte Nogo-A and increases axonal sprouting in a rodent model for human prematurity. Exp Neurol 2004; 189(1):141–9.
18. Fagel DM, Ganat Y, Silbereis J, et al. Cortical neurogenesis enhanced by chronic perinatal hypoxia. Exp Neurol 2006;199(1):77–91.
19. Ganat Y, Soni S, Chacon M, Schwartz ML, Vaccarino FM. Chronic hypoxia up-regulates fibroblast growth factor ligands in the perinatal brain and induces fibroblast growth factor-responsive radial glial cells in the sub-ependymal zone. Neuroscience 2002;112(4):977–91.
20. Johnston MV, Nakajima W, Hagberg H. Mechanisms of hypoxic neurodegeneration in the developing brain. Neuroscientist 2002;8(3):212–20.
21. Jensen FE. Developmental factors regulating susceptibility to perinatal brain injury and seizures. Curr Opin Pediatr 2006;18(6):628–33.
22. McQuillen PS, Ferriero DM. Selective vulnerability in the developing central nervous system. Pediatr Neurol 2004;30(4):227–35.
23. Matute C, Alberdi E, Ibarretxe G, Sanchez-Gomez MV. Excitotoxicity in glial cells. Eur J Pharmacol 2002;447(2–3):239–46.
24. du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002;15(2):151–7.
25. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res Bull 1998;46(4):281–309.
26. Kanaan A, Farahani R, Douglas RM, Lamanna JC, Haddad GG. Effect of chronic continuous or intermittent hypoxia and reoxygenation on cerebral capillary density and myelination. Am J Physiol Regul Integr Comp Physiol 2006;290(4):R1105–R1114.
27. Baumgartner RW, Eichenberger U, Bartsch P. Postural ataxia at high altitude is not related to mild to moderate acute mountain sickness. Eur J Appl Physiol 2002;86(4):322–6.
28. Shukitt-Hale B, Kadar T, Marlowe BE, et al. Morphological alterations in the hippocampus following hypobaric hypoxia. Hum Exp Toxicol 1996;15(4):312–19.
29. Singh SB, Selvamurthy W. Effect of intermittent chronic exposure to hypoxia on feeding behaviour of rats. Int J Biometeorol 1993;37(4):200–2.
30. Bahrke MS, Shukitt-Hale B. Effects of altitude on mood, behaviour and cognitive functioning. A review. Sports Med 1993;16(2):97–125.
31. Hamilton AJ, Trad LA, Cymerman A. Alterations in human upper extremity motor function during acute exposure to simulated altitude. Aviat Space Environ Med 1991;62(8):759–64.
32. Urschitz MS, Eitner S, Guenther A, et al. Habitual snoring, intermittent hypoxia, and impaired behavior in primary school children. Pediatrics 2004;114(4):1041–8.
33. Noda A, Okada T, Yasuma F, Nakashima N, Yokota M. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995;107(6):1538–44.
34. Winnicki M, Shamsuzzaman A, Lanfranchi P, et al. Erythropoietin and obstructive sleep apnea. Am J Hypertens 2004;17(9):783–6.
35. Halbower AC, Degaonkar M, Barker PB, et al. Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med 2006;3(8):e301.
36. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998; 102(3, Part 1):616–20.
37. Barhwal K, Singh SB, Hota SK, Jayalakshmi K, Ilavazhagan G. Acetyl-l-carnitine ameliorates hypobaric hypoxic impairment and spatial memory deficits in rats. Eur J Pharmacol 2007;570(1–3):97–107.
38. Hogan AM, Pit-ten Cate IM, Vargha-Khadem F, Prengler M, Kirkham FJ. Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction. Dev Sci 2006;9(4):379–87.
39. Freeman GB, Nielsen P, Gibson GE. Monoamine neurotransmitter metabolism and locomotor activity during chemical hypoxia. J Neurochem 1986;46(3):733–8.
40. Zola-Morgan S, Squire LR, Rempel NL, Clower RP, Amaral DG. Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J Neurosci 1992;12(7):2582–96.
41. Tsien JZ, Huerta PT, Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 1996;87(7):1327–38.
42. Tonegawa S, Tsien JZ, McHugh TJ, Huerta P, Blum KI, Wilson MA. Hippocampal CA1-region-restricted knockout of NMDAR1 gene disrupts synaptic plasticity, place fields, and spatial learning. Cold Spring Harb Symp Quant Biol 1996;61:225–38.
43. Rempel-Clower NL, Zola SM, Squire LR, Amaral DG. Three cases of enduring memory impairment after bilateral damage limited to the hippocampal formation. J Neurosci 1996;16(16): 5233–55.
44. Dugan LL, Creedon DJ, Johnson EM, Jr., Holtzman DM. Rapid suppression of free radical formation by nerve growth factor involves the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 1997;94(8):4086–91.
45. Alvarez P, Zola-Morgan S, Squire LR. Damage limited to the hippocampal region produces long-lasting memory impairment in monkeys. J Neurosci 1995;15(5, Part 2):3796–807.
46. McHugh TJ, Blum KI, Tsien JZ, Tonegawa S, Wilson MA. Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell 1996;87(7):1339–49.
47. Mikati MA, Zeinieh MP, Kurdi RM, et al. Long-term effects of acute and of chronic hypoxia on behavior and on hippocampal histology in the developing brain. Brain Res Dev Brain Res 2005;157(1):98–102.
48. Maiese K, Li F, Chong ZZ. Erythropoietin in the brain: can the promise to protect be fulfilled? Trends Pharmacol Sci 2004;25(11):577–83.
49. Kirkham FJ, Datta AK. Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability. Dev Sci 2006;9(4):411–27.
50. Virues-Ortega J, Garrido E, Javierre C, Kloezeman KC. Human behaviour and development under high-altitude conditions. Dev Sci 2006;9(4):400–10.
51. Lieberman P, Protopapas A, Reed E, Youngs JW, Kanki BG. Cognitive defects at altitude. Nature 1994;372(6504):325.
52. Askew EW. Work at high altitude and oxidative stress: antioxidant nutrients. Toxicology 2002; 180(2):107–19.
53. Pearigen P, Gwinn R, Simon RP. The effects in vivo of hypoxia on brain injury. Brain Res 1996;725(2):184–91.
54. Tamatani M, Mitsuda N, Matsuzaki H, et al. A pathway of neuronal apoptosis induced by hypoxia/reoxygenation: roles of nuclear factor-kappaB and Bcl-2. J Neurochem 2000;75(2): 683–93.
55. Matsuoka Y, Kitamura Y, Fukunaga R, et al. In vivo hypoxia-induced neuronal damage in dentate gyrus of rat hippocampus: changes in NMDA receptors and the effect of MK-801. Neurochem Int 1997;30(6):533–42.
56. Dell’Anna ME, Calzolari S, Molinari M, Iuvone L, Calimici R. Neonatal anoxia induces transitory hyperactivity, permanent spatial memory deficits and CA1 cell density reduction in developing rats. Behav Brain Res 1991;45(2):125–34.
57. Chihab R, Bossenmeyer C, Oillet J, Daval JL. Lack of correlation between the effects of transient exposure to glutamate and those of hypoxia/reoxygenation in immature neurons in vitro. J Neurochem 1998;71(3):1177–86.
58. Bossenmeyer C, Chihab R, Muller S, Schroeder H, Daval JL. Hypoxia/reoxygenation induces apoptosis through biphasic induction of protein synthesis in cultured rat brain neurons. Brain Res 1998;787(1):107–16.
59. Banasiak KJ, Haddad GG. Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res 1998;797(2):295–304.
60. Grojean S, Pourie G, Vert P, Daval JL. Differential neuronal fates in the CA1 hippocampus after hypoxia in newborn and 7-day-old rats: effects of pre-treatment with MK-801. Hippocampus 2003;13(8):970–7.
61. Aitken PG, Balestrino M, Somjen GG. NMDA antagonists: lack of protective effect against hypoxic damage in CA1 region of hippocampal slices. Neurosci Lett 1988;89(2):187–92.
62. Zhu C, Wang X, Xu F, et al. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 2005;12(2):162–76.
63. Pulsinelli WA. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res 1985;63:29–37.
64. Erecinska M, Silver IA. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 2001;128(3):263–76.
65. Knickerbocker DL, Lutz PL. Slow ATP loss and the defense of ion homeostasis in the anoxic frog brain. J Exp Biol 2001;204 (Part 20):3547–51.
66. Hansen AJ. Effect of anoxia on ion distribution in the brain. Physiol Rev 1985;65(1):101–48.
67. Nilsson GE. Surviving anoxia with the brain turned on. News Physiol Sci 2001;16:217–21.
68. Hochachka PW, Lutz PL. Mechanism, origin, and evolution of anoxia tolerance in animals. Comp Biochem Physiol B Biochem Mol Biol 2001;130(4):435–59.
69. Back SA, Han BH, Luo NL, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002;22(2):455–63.
70. Nieber K. Hypoxia and neuronal function under in vitro conditions. Pharmacol Ther 1999; 82(1):71–86.
71. Donnelly DF, Jiang C, Haddad GG. Comparative responses of brain stem and hippocampal neurons to O2 deprivation: in vitro intracellular studies. Am J Physiol 1992;262(5, Part 1): L549–L554.
72. Kadar T, Dachir S, Shukitt-Hale B, Levy A. Sub-regional hippocampal vulnerability in various animal models leading to cognitive dysfunction. J Neural Transm 1998;105(8–9):987–1004.
73. Gibson GE, Pulsinelli W, Blass JP, Duffy TE. Brain dysfunction in mild to moderate hypoxia. Am J Med 1981;70(6):1247–54.
74. Cervos-Navarro J, Diemer NH. Selective vulnerability in brain hypoxia. Crit Rev Neurobiol 1991;6(3):149–82.
75. Erecinska M, Silver IA. Calcium handling by hippocampal neurons under physiologic and pathologic conditions. Adv Neurol 1996;71:119–36.
76. Ramanathan L, Gozal D, Siegel JM. Antioxidant responses to chronic hypoxia in the rat cerebellum and pons. J Neurochem 2005;93(1):47–52.
77. Xu L, Sapolsky RM, Giffard RG. Differential sensitivity of murine astrocytes and neurons from different brain regions to injury. Exp Neurol 2001;169(2):416–24.
78. Hammarstrom AK, Gage PW. Inhibition of oxidative metabolism increases persistent sodium current in rat CA1 hippocampal neurons. J Physiol 1998;510 (Part 3):735–41.
79. + channel independently of cytosolic factors in rat central neurons. J Physiol 1994;481 (Part 1):15–26.
80. Peers C. Oxygen-sensitive ion channels. Trends Pharmacol Sci 1997;18(11):405–8.
81. + channels. Annu Rev Physiol 1997;59:23–42.
82. Lopez-Barneo J. Oxygen-sensing by ion channels and the regulation of cellular functions. Trends Neurosci 1996;19(10):435–40.
83. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999;15:551–78.
84. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004;5(5):343–54.
85. +-dependent transport. Exp Neurol 1997;146(2):403–13.
86. Shimoda LA, Fallon M, Pisarcik S, Wang J, Semenza GL. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am J Physiol Lung Cell Mol Physiol 2006;291(5):L941–L949.
87. Chen LM, Choi I, Haddad GG, Boron WF. Chronic continuous hypoxia decreases the expression of SLC4A7 (NBCn1) and SLC4A10 (NCBE) in mouse brain. Am J Physiol Regul Integr Comp Physiol 2007;293(6):R2412–R2420.
88. Xue J, Zhou D, Yao H, Haddad GG. Role of transporters and ion channels in neuronal injury under hypoxia. Am J Physiol Regul Integr Comp Physiol 2008;294(2):R451–R457.
89. + exchanger subunit 1 and HCO3-transporters in regulating neuronal cell fate in prolonged hypoxia. Am J Physiol Regul Integr Comp Physiol 2008;294(2):R448–R450.
90. Heacock CS, Sutherland RM. Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism. Br J Cancer 1990;62(2):217–25.
91. Hochachka PW, Buck LT, Doll CJ, Land SC. Unifying theory of hypoxia tolerance: molecu-lar/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci USA 1996;93(18):9493–8.
92. Storey KB, Storey JM. Metabolic rate depression in animals: transcriptional and translational controls. Biol Rev Camb Philos Soc 2004;79(1):207–33.
93. Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997;77(3):731–58.
94. Hochachka PW. Defense strategies against hypoxia and hypothermia. Science 1986;231(4735): 234–41.
95. Raley-Susman KM, Murata J. Time course of protein changes following in vitro ischemia in the rat hippocampal slice. Brain Res 1995;694(1–2):94–102.
96. Raley-Susman KM, Lipton P. In vitro ischemia and protein synthesis in the rat hippocampal slice: the role of calcium and NMDA receptor activation. Brain Res 1990;515(1–2):27–38.
97. Arsham AM, Howell JJ, Simon MC. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem 2003;278(32):29655–60.
98. Koumenis C, Naczki C, Koritzinsky M, et al. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol Cell Biol 2002;22(21):7405–16.
99. Chavez JC, Pichiule P, Boero J, Arregui A. Reduced mitochondrial respiration in mouse cerebral cortex during chronic hypoxia. Neurosci Lett 1995;193(3):169–72.
100. Lai JC, White BK, Buerstatte CR, Haddad GG, Novotny EJ, Jr., Behar KL. Chronic hypoxia in development selectively alters the activities of key enzymes of glucose oxidative metabolism in brain regions. Neurochem Res 2003;28(6):933–40.
101. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3(3):187–97.
102. Chinopoulos C, Adam-Vizi V. Depolarization of in situ mitochondria by hydrogen peroxide in nerve terminals. Ann N Y Acad Sci 1999;893:269–72.
103. Murphy BJ, Robin ED, Tapper DP, Wong RJ, Clayton DA. Hypoxic coordinate regulation of mitochondrial enzymes in mammalian cells. Science 1984;223(4637):707–9.
104. Boutilier RG. Mechanisms of cell survival in hypoxia and hypothermia. J Exp Biol 2001;204 (Part 18):3171–81.
105. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986;19(2):105–11.
106. Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci 1990;11(11):462–8.
107. Choi DW. Possible mechanisms limiting N-methyl-d-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-d-aspartate antagonists. Stroke 1990;21(11 Suppl): III20–III22.
108. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999;79(4):1431–568.
109. Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 1999;399(6738 Suppl):A7–A14.
110. Puka-Sundvall M, Hallin U, Zhu C, et al. NMDA blockade attenuates caspase-3 activation and DNA fragmentation after neonatal hypoxia-ischemia. Neuroreport 2000;11(13):2833–6.
111. Wang X, Karlsson JO, Zhu C, Bahr BA, Hagberg H, Blomgren K. Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia. Biol Neonate 2001;79(3–4):172–9.
112. Hu BR, Liu CL, Ouyang Y, Blomgren K, Siesjo BK. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 2000;20(9):1294–300.
113. Bossenmeyer-Pourie C, Lievre V, Grojean S, Koziel V, Pillot T, Daval JL. Sequential expression patterns of apoptosis-and cell cycle-related proteins in neuronal response to severe or mild transient hypoxia. Neuroscience 2002;114(4):869–82.
114. Blomgren K, Leist M, Groc L. Pathological apoptosis in the developing brain. Apoptosis 2007;12(5):993–1010.
115. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80(2):293–9.
116. Tamatani M, Ogawa S, Tohyama M. Roles of Bcl-2 and caspases in hypoxia-induced neuronal cell death: a possible neuroprotective mechanism of peptide growth factors. Brain Res Mol Brain Res 1998;58(1–2):27–39.
117. Forman HJ, Zhou H, Gozal E, Torres M. Modulation of the alveolar macrophage superoxide production by protein phosphorylation. Environ Health Perspect 1998;106 Suppl 5: 1185–90.
118. Cadenas E. Biochemistry of oxygen toxicity. Annu Rev Biochem 1989;58:79–110.
119. Kulkarni AC, Kuppusamy P, Parinandi N. Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy. Antioxid Redox Signal 2007;9(10):1717–30.
120. St-Pierre J, Brand MD, Boutilier RG. Mitochondria as ATP consumers: cellular treason in anoxia. Proc Natl Acad Sci USA 2000;97(15):8670–4.
121. Capdevila J, Chacos N, Werringloer J, Prough RA, Estabrook RW. Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Proc Natl Acad Sci USA 1981;78(9):5362–6.
122. Babior BM. NADPH oxidase: an update. Blood 1999;93(5):1464–76.
123. Masoro EJ. Caloric restriction and aging: an update. Exp Gerontol 2000;35(3):299–305.
124. Dugan LL, Quick KL. Reactive oxygen species and aging: evolving questions. Sci Aging Knowledge Environ 2005;2005(26):pe20.
125. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90(17):7915–22.
126. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996;36:83–106.
127. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38(3):357–66.
128. Pouyssegur J, Mechta-Grigoriou F. Redox regulation of the hypoxia-inducible factor. Biol Chem 2006;387(10–11):1337–46.
129. Pidgeon GP, Tamosiuniene R, Chen G, et al. Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2. Circulation 2004;110(17): 2701–7.
130. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 2006;91(5):807–19.
131. Dawson TL, Gores GJ, Nieminen AL, Herman B, Lemasters JJ. Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am J Physiol 1993;264 (4, Part 1):C961–C967.
132. Clanton T. Yet another oxygen paradox. J Appl Physiol 2005;99(4):1245–6.
133. Siddappa AJ, Rao RB, Wobken JD, Leibold EA, Connor JR, Georgieff MK. Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain. J Neurosci Res 2002;68(6):761–75.
134. McQuillen PS, Sheldon RA, Shatz CJ, Ferriero DM. Selective vulnerability of subplate neurons after early neonatal hypoxia-ischemia. J Neurosci 2003;23(8):3308–15.
135. Schumacker PT. Current paradigms in cellular oxygen sensing. Adv Exp Med Biol 2003; 543:57–71.
136. Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 1998;273(19):11619–24.
137. Won SJ, Kim DY, Gwag BJ. Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol 2002;35(1):67–86.
138. Adams JH. Brain damage caused by cerebral hypoxia. Nurs Times 1975;71(17):654–6.
139. Waypa GB, Schumacker PT. O(2) sensing in hypoxic pulmonary vasoconstriction: the mitochondrial door re-opens. Respir Physiol Neurobiol 2002;132(1):81–91.
140. Schroedl C, McClintock DS, Budinger GR, Chandel NS. Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 2002;283(5):L922–L931.
141. Maiti P, Singh SB, Sharma AK, Muthuraju S, Banerjee PK, Ilavazhagan G. Hypobaric hypoxia induces oxidative stress in rat brain. Neurochem Int 2006;49(8):709–16.
142. Watson BD, Ginsberg MD, Busto R. Macroscopic indices of lipid peroxidation in cerebral ischemia/reperfusion: validity and sensitivity enhancement in terms of conjugated diene detection. Neurochem Int 1996;29(2):173–86.
143. Li RC, Row BW, Kheirandish L, et al. Nitric oxide synthase and intermittent hypoxia-induced spatial learning deficits in the rat. Neurobiol Dis 2004;17(1):44–53.
144. Mishra OP, Delivoria-Papadopoulos M. Cellular mechanisms of hypoxic injury in the developing brain. Brain Res Bull 1999;48(3):233–8.
145. Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985;240(2):500–8.
146. Barker JE, Bolanos JP, Land JM, Clark JB, Heales SJ. Glutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage: implications for neuronal/astrocytic trafficking and neurodegeneration. Dev Neurosci 1996;18(5–6):391–6.
147. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984;43(5):1369–74.
148. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 1989; 2(6):1547–58.
149. Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies KJ. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 1990;265(27):16330–6.
150. Singh SN, Vats P, Kumria MM, et al. Effect of high altitude (7,620 m) exposure on glutathione and related metabolism in rats. Eur J Appl Physiol 2001;84(3):233–7.
151. Moller P, Loft S, Lundby C, Olsen NV. Acute hypoxia and hypoxic exercise induce DNA strand breaks and oxidative DNA damage in humans. FASEB J 2001;15(7):1181–6.
152. Jayalakshmi K, Sairam M, Singh SB, Sharma SK, Ilavazhagan G, Banerjee PK. Neuroprotective effect of N-acetyl cysteine on hypoxia-induced oxidative stress in primary hippocampal culture. Brain Res 2005;1046(1–2):97–104.
153. Bailey DM, Davies B. Acute mountain sickness: prophylactic benefits of antioxidant vitamin supplementation at high altitude. High Alt Med Biol 2001;2(1):21–9.
154. Sattler R, Tymianski M. Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med 2000;78(1):3–13.
155. Dugan LL, Sensi SL, Canzoniero LM, et al. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-d-aspartate. J Neurosci 1995; 15(10):6377–88.
156. Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci 1998;1(5):366–73.
157. Luetjens CM, Bui NT, Sengpiel B, et al. Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production. J Neurosci 2000;20(15):5715–23.
158. Sengpiel B, Preis E, Krieglstein J, Prehn JH. NMDA-induced superoxide production and neurotoxicity in cultured rat hippocampal neurons: role of mitochondria. Eur J Neurosci 1998;10(5):1903–10.
159. Shimizu S, Eguchi Y, Kamiike W, et al. Involvement of ICE family proteases in apoptosis induced by reoxygenation of hypoxic hepatocytes. Am J Physiol 1996;271(6, Part 1): G949–G958.
160. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275(5303):1132–6.
161. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281(5381):1309–12.
162. Facchinetti F, Dawson VL, Dawson TM. Free radicals as mediators of neuronal injury. Cell Mol Neurobiol 1998;18(6):667–82.
163. Ock J, Jeong J, Choi WS, et al. Regulation of toll-like receptor 4 expression and its signaling by hypoxia in cultured microglia. J Neurosci Res 2007;85(9):1989–95.
164. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000;18:621–63.
165. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109 Suppl: S81–S96.
166. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immunol 2002;3(1):20–6.
167. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994;10:405–55.
168. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996;87(1):13–20.
169. Cario E, Podolsky DK. Intestinal epithelial TOLLerance versus inTOLLerance of commen-sals. Mol Immunol 2005;42(8):887–93.
170. Cummins EP, Berra E, Comerford KM, et al. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci USA 2006;103(48):18154–9.
171. Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006;2006(357):re13.
172. Rius J, Guma M, Schachtrup C, et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008;453:807–811.
173. Kitajima I, Nakajima T, Imamura T, et al. Induction of apoptosis in murine clonal osteoblasts expressed by human T-cell leukemia virus type I tax by NF-kappa B and TNF-alpha. J Bone Miner Res 1996;11(2):200–10.
174. Kessler JA, Ludlam WH, Freidin MM, et al. Cytokine-induced programmed death of cultured sympathetic neurons. Neuron 1993;11(6):1123–32.
175. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 1996;274(5291):1383–5.
176. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996;274(5288):782–4.
177. 2+ accumulation. Proc Natl Acad Sci USA 1995;92(20):9328–32.
178. Koong AC, Chen EY, Giaccia AJ. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res 1994;54(6): 1425–30.
179. Chandel NS, McClintock DS, Feliciano CE, et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 2000;275(33):25130–8.
180. Zampetaki A, Mitsialis SA, Pfeilschifter J, Kourembanas S. Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: the prominent role of p42/ p44 and PI3 kinase pathways. FASEB J 2004;18(10):1090–2.
181. Clemens JA, Stephenson DT, Yin T, Smalstig EB, Panetta JA, Little SP. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats. Stroke 1998;29(3):677–82.
182. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998;396(6706):77–80.
183. Grilli M, Goffi F, Memo M, Spano P. Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem 1996;271(25):15002–7.
184. Schmitz ML, Baeuerle PA. Multi-step activation of NF-kappa B/Rel transcription factors. Immunobiology 1995;193(2–4):116–27.
185. Sairanen T, Carpen O, Karjalainen-Lindsberg ML, et al. Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 2001;32(8):1750–8.
186. Acker T, Acker H. Cellular oxygen sensing need in CNS function: physiological and pathological implications. J Exp Biol 2004;207 (Part 18):3171–88.
187. Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 2007;19(2):223–9.
188. Plas DR, Thompson CB. Akt-dependent transformation: there is more to growth than just surviving. Oncogene 2005;24(50):7435–42.
189. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270(3):1230–7.
190. Ratcliffe PJ. HIF-1 and HIF-2: working alone or together in hypoxia? J Clin Invest 2007; 117(4):862–5.
191. Maxwell PH. Hypoxia-inducible factor as a physiological regulator. Exp Physiol 2005; 90(6):791–7.
192. Wiesener MS, Turley H, Allen WE, et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 1998;92(7):2260–8.
193. Kaelin WG, Jr. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res Commun 2005;338(1):627–38.
194. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002;16(12):1466–71.
195. Stroka DM, Burkhardt T, Desbaillets I, et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 2001;15(13):2445–53.
196. Sharp FR, Bergeron M, Bernaudin M. Hypoxia-inducible factor in brain. Adv Exp Med Biol 2001;502:273–91.
197. Arany Z, Huang LE, Eckner R, et al. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 1996;93(23):12969–73.
198. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001;412(6847):641–7.
199. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146(5):1029–39.
200. Rapino C, Bianchi G, Di Giulio C, et al. HIF-1alpha cytoplasmic accumulation is associated with cell death in old rat cerebral cortex exposed to intermittent hypoxia. Aging Cell 2005;4(4):177–85.
201. Halterman MW, Federoff HJ. HIF-1alpha and p53 promote hypoxia-induced delayed neuronal death in models of CNS ischemia. Exp Neurol 1999;159(1):65–72.
202. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998;394(6692):485–90.
203. Hagen T, Taylor CT, Lam F, Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 2003;302(5652):1975–8.